Steris plc at Raymond James Institutional Investors Conference Transcript
Okay. Good morning, everyone. Welcome to the Annual Raymond James Institutional Investors Conference.
We're excited to have with us this morning, kicking off the meeting this year, STERIS. STERIS has really seen some terrific growth over the last year and change. They have really seen all parts of their businesses firing on all cylinders, driving margin expansion and deploying capital effectively, so extremely well positioned.
With us today to give an update on the story is Mike Tokich. Mike is the Senior Vice President and Chief Financial Officer at STERIS; and in the audience is Julie Winter, who is the Director of Investor Relations and Corporate Communications. So with that, Mike, I'll turn it over to you.
Great. Thank you, Larry. Good morning, everybody. It's my pleasure to be here to talk about one of my favorite subjects, STERIS. As Larry said, we've had a fantastic year. Our year does end in less
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
